Summary
- Current Price
- As of today, RMD price is $219.58, down -0.17% on
- Current Price All-Time High
- RMD price is currently -27.13% below its historical high of $301.34 set on
- Market Cap
- RMD current market cap is $32B, down -20.00% year-over-year
- PE Ratio
- RMD current PE ratio is 21.04
- Revenue
- RMD current annual revenue is $5.65B, up +9.85% year-over-year
- Next Earnings
- The next earnings release for RMD is on
Profile
| Metric | Value |
|---|---|
| Full Name | ResMed Inc. |
| Ticker | NYSE: RMD |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | |
| Website | resmed.co.in |
| Employees | 11,370 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $219.58 | |
| Price, 1D Change | -0.17% | |
| Market Cap | $32B | |
| TTM Dividend Yield | 1.12% | |
| PE Ratio | 21.04 | |
| Beta | 0.46 | |
| Revenue | $5.65B | |
| Revenue, 1Y Change | +9.85% | |
| EPS | $10.43 | |
| EPS, 1Y Change | +9.71% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.66 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $10.43 | |
| EPS Estimate | $12.08 | N/A |
| EPS Est. Change | +15.83% | N/A |
| Revenue | $5.65B | |
| Revenue Estimate | $5.81B | N/A |
| Revenue Est. Change | +2.78% | N/A |
| Current Price | $219.58 | |
| Price Target | $235.00 | - |
| Price Tgt. Change | +7.02% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.50 | $9.51 | +0.06% | |
| $11.12 | $10.43 | -6.24% | |
| $12.08 | N/A | +15.83% | |
| $13.21 | N/A | +26.68% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.13B | $5.15B | +0.37% | |
| $5.65B | $5.65B | +0.05% | |
| $5.81B | N/A | +2.78% | |
| $6.19B | N/A | +9.48% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -18.82% | |
| Price, 3Y | +48.42% | |
| Market Cap, 1Y | -20.00% | |
| Market Cap, 3Y | +45.58% | |
| Revenue, 1Y | +9.85% | |
| Revenue, 3Y | +33.87% | |
| EPS, 1Y | +9.71% | |
| EPS, 3Y | +71.34% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $219.58 | |
| SMA 200 | $228.02 | |
| SMA 50 | $216.62 | |
| EMA 200 | $225.12 | |
| EMA 50 | $219.70 | |
| MACD | $1.94 | |
| Beta | 0.46 | |
| ATR | $6.47 | |
| 14-Day RSI | 43.69 | |
| 10-Day Volatility | 25.62% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.66 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 1.09% | |
| Total Dividend | $2.40 | |
| $349.66M | ||
| 22.95% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $5.65B | |
| EPS | $10.43 | |
| Gross Profit | $3.41B | |
| Gross Margin | 60.25% | |
| Operating Income | $1.92B | |
| Operating Margin | 33.96% | |
| Net Income | $1.52B | |
| Net Margin | 26.94% | |
| EBITDA | $2.16B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.13 | |
| 3.10 | ||
| 2.42 | ||
| - | ||
| 6 | ||
| 10.85 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 21.04 | |
| 5.60 | ||
| 4.81 | ||
| 14.32 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $6.59B | |
| $1.47B | ||
| $8.97B | ||
| $4.32B | ||
| $2.38B | ||
| $1.40B | ||
| Total Debt | $825.92M | |
| $289.09M | ||
| $308.92M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $4.13B | ||
| $1.49B | ||
| $2.25B | ||
| $0.00 | ||
| $244.15M | ||
| $0.00 | ||
| $396.12M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $1.81B | ||
| -$545.20M | ||
| -$1.01B | ||
| Capex | $177.17M | |
| $1.63B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Keybanc | → | |
| Rothschild & Co | ||
| Wells Fargo | → | |
| RBC Capital | → | |
| Piper Sandler | → | |
| Keybanc | → | |
| Mizuho | → | |
| Citigroup | → | |
| Jefferies | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with RMD
FAQ
- What is the ticker symbol for ResMed Inc.?
- The ticker symbol for ResMed Inc. is NYSE:RMD
- Does ResMed Inc. pay dividends?
- Yes, ResMed Inc. pays dividends. The last payment was $0.66, with an ex-dividend date on August 20, 2026
- What sector is ResMed Inc. in?
- ResMed Inc. is in the Healthcare sector
- What industry is ResMed Inc. in?
- ResMed Inc. is in the Medical Instruments & Supplies industry
- What country is ResMed Inc. based in?
- ResMed Inc. is headquartered in United States
- When did ResMed Inc. go public?
- ResMed Inc. initial public offering (IPO) was on June 2, 1995
- Is ResMed Inc. in the S&P 500?
- Yes, ResMed Inc. is included in the S&P 500 index
- Is ResMed Inc. in the NASDAQ 100?
- No, ResMed Inc. is not included in the NASDAQ 100 index
- Is ResMed Inc. in the Dow Jones?
- No, ResMed Inc. is not included in the Dow Jones index
- When was ResMed Inc. last earnings report?
- ResMed Inc.'s most recent earnings report was on August 6, 2026
- When does ResMed Inc. report earnings?
- The next expected earnings date for ResMed Inc. is October 29, 2026
Data Sources & References
- RMD Official Website www.resmed.co.in
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- RMD Profile on Yahoo Finance finance.yahoo.com/quote/RMD
- RMD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rmd